Serum Institute of India to invest $68 million in UK's Oxford Biomedica
Oxford Biomedica is one of the COVID-19 vaccine manufacturers for drug major AstraZeneca
SII has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October. Source: PTI